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Aim:  Neuropsychological  testing  has  uncovered  cognitive  impairment  in  cardiac  arrest  survivors  with
good neurologic  outcome  according  to the  cerebral  performance  categories.  We  investigated  cognitive
function  and  health-related  quality  of  life  four  years  after  cardiac  arrest.
Methods:  Thirty  cardiac  arrest  survivors  over  the age  of  18  in cerebral  performance  category  1 or  2 on
hospital  discharge  completed  the EQ-5D-5L  and  HADS  questionnaires  prior  to  cognitive  testing  using
the Cambridge  Neuropsychological  Test Automated  Battery.  The  results  were  compared  with  population
norms.
Results:  Twenty-nine  per cent  of patients  were  cognitively  impaired.  The  pattern  of  cognitive  impairmentANTAB
europsychological tests
uality of life
reatment outcome
reﬂects  dysfunction  in the medial  temporal  lobe,  with  impaired  short-time  memory  and executive  func-
tion slightly  but  distinctly  affected.  There  was a signiﬁcant  reduction  in  quality  of  life  on  the  EQ-VAS,  but
not on  the  EQ index.
Conclusion:  Cognitive  impairment  four  years  after  cardiac  arrest  affected  more  than  one quarter  of the
patients.  Short-term  memory  was  predominantly  affected.
rs.  Pu©  2015  The  Autho
. Introduction1
Cognitive function in cardiac arrest (CA) survivors is reported to
e favourable in the majority of patients.1–3 The most frequently
sed cognitive outcome has been the cerebral performance cate-
ories (CPC) upon discharge, as speciﬁed in the Utstein template.4,5
 A Spanish translated version of the summary of this article appears as Appendix
n the ﬁnal online version at http://dx.doi.org/10.1016/j.resuscitation.2014.12.021.
∗ Corresponding author at: Helse Bergen HF, Haukeland University Hospital,
epartment of Anaesthesia and Intensive Care, Jonas Lies Veg 65, NO-5021 Bergen,
orway.
E-mail address: eirik.alnes.buanes@helse-bergen.no (E.A. Buanes).
1 List of uncommon abbreviations: HADS, Hospital Anxiety and Depression rat-
ng Scale; CANTAB, Cambridge Neuropsychological Test Automated Battery; MOT,
otor Screening (test in CANTAB); PAL, Paired Associates Learning (test in CANTAB);
MS,Delayed Matching to Sample (test in CANTAB); SOC, Stockings of Cambridge
test in CANTAB); IED, intra-/extradimensional set shift (test in CANTAB).
ttp://dx.doi.org/10.1016/j.resuscitation.2014.12.021
300-9572/© 2015 The Authors. Published by Elsevier Ireland Ltd. This is an open access 
http://creativecommons.org/licenses/by-nc-nd/4.0/).blished  by Elsevier  Ireland  Ltd.  This  is an open  access  article  under  the CC
BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).
After its introduction in 1975, the CPC became an important tool for
improving the assessment of outcomes after severe brain damage.
In recent decades, it has become increasingly evident that the CPC
is too crude to assess more subtle changes in cognitive function that
may  appear after CA. Neuropsychological testing has uncovered
cognitive impairment in CA survivors with good cerebral outcome
according to the CPC.6–8 The use of CPC as a robust cerebral outcome
measure has therefore been questioned.9
With regard to diagnostic accuracy, traditional neuropsycholo-
gical testing provides a detailed assessment of cerebral function.
The drawback is that the method is time-consuming and requires
highly specialised personnel. The ideal diagnostic tool for clinical
use must provide a sufﬁciently detailed assessment of cognitive
function and be easy to administer. We have previously used the
Cambridge Neuropsychological Test Automated Battery (CANTAB)
on a CA population treated with therapeutic hypothermia.10 The
method is suited to clinical work and comparison across different
cultures and languages.11 In this study, we test the hypothesis that
article under the CC BY-NC-ND license
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Discharged alive
n = 61
Unknown ID
n = 1
Dead before study start
n = 14
Alive at study start
n = 46
Excluded (n = 16)
Declined to participate: 11
CPC > 2: 4
Could no t be reached : 1
Included in study
n = 30
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aFig. 1. Flow chart showing included and excluded patients.
ognitive impairment persists in long-term CA survivors with good
erebral outcome according to the CPC compared with an age and
ender-matched population norm. Our secondary objectives were
o investigate health-related quality of life and whether primary
hockable rhythm, the location of CA, therapeutic hypothermia or
ength of stay in the intensive care unit (ICU) could predict long-
erm cognitive function after CA.
. Methods
.1. Patients
Subjects from a cohort of patients discharged alive after cardiac
rrest in Bergen between 1 December 2008 and 30 November 2009,
bove the age of 18 and alive in October 2012, were considered
or inclusion. Data from this patient cohort have previously been
ublished.12 Patients with a CPC above 2 on hospital discharge and
atients who could not be reached or had an unknown identity
ere excluded (Fig. 1). The patients included were tested at a single
ime point a median of 3.6 years (ICR: 3.4–3.8) after CA.
.2. Test setting
The Hospital Anxiety and Depression rating Scale (HADS) (Age-
ng and health, Oslo University Hospital, Ullevål, Bygn. 37, 0407
slo, Norway) and the EQ-5D-5L (EuroQol Group, Marten Meesweg
07, 3068 AV Rotterdam, the Netherlands) were sent by post to all
ligible patients, along with written information about the study,
 consent form and a pre-paid return envelope. Participants who
eturned the initial forms were contacted by telephone to schedule
ognitive testing. Participants who did not return the forms were
ontacted by telephone for consent. If consent was given, they were
eminded to return the forms and cognitive testing was  scheduled.
ANTAB (Cambridge Cognition, Tunbridge Court, Tunbridge Lane,
ottisham, Cambridge CB25 9TU) test sessions took place at Hauke-
and University Hospital and lasted approximately one hour. For
articipants unable to travel to the hospital, testing was arranged
t a health facility nearer where they lived.tion 89 (2015) 13–18
2.3. Test methods
EQ-5D-5L was used to evaluate health-related quality of life.
EQ-5D-5L is a self-administered questionnaire assessing ﬁve
dimensions of health. It has ﬁve levels for each dimension and
an overall self-estimate of health on a visual analogue scale (EQ-
VAS). The ﬁve dimensions are mobility, self-care, usual activities,
pain/discomfort and anxiety/depression. We  report EQ-VAS and
health index (EQ-index) calculated on the basis of values for the
ﬁve dimensions.13
HADS was used to screen for anxiety and depression. It
is a self-administered questionnaire that yields separate scores
for depression and anxiety.14 A score ≥8 indicates anxiety or
depression.15
Cognitive function was  measured using CANTAB,11 a touch-
screen, computer-based cognitive function assessment tool
featuring a total of 22 tests for several cognitive domains. Language
proﬁciency is only needed for the verbal instructions prior to each
test, since all task stimuli are non-verbal, consisting of geometric
designs or simple shapes. We  assembled a battery of ﬁve tests to
assess memory and executive functions. Assistants can adminis-
ter the test battery in 50–70 min  and the results are immediately
available. Several outcome measures are available for each test,
reported either as a raw score or z-score. The z-score is the num-
ber of standard deviations the patient’s score differs from an age
and gender-matched British population mean. For the classiﬁcation
of cognitive impairment (CI), we  report z-scores from ten param-
eters based on test–retest reliability.16 Five of the ten parameters
represent memory and ﬁve represent executive function. Cognitive
impairment was deﬁned as having two  out of ten z-scores below
−2.0, or three out of ten z-scores below −1.5.17 The test battery
consisted of the following tests:
2.3.1. Motor Screening
A simple introduction to the test apparatus and screening for
visual and motor impairment that may interfere with cognitive
testing. The subject has to touch X-marks of different colours on
the screen as they appear.
2.3.2. Paired Associates Learning (PAL)
A test of visual episodic memory and learning. Six or eight boxes
are displayed. All of them are opened in random order, and some
contain a pattern. The patterns are then displayed one at a time,
and the subject must touch the box where each pattern is hidden.
The test becomes progressively more difﬁcult in eight stages. If the
subject makes an error, patterns in that stage are re-presented. The
test terminates after ten trials in any given stage.
2.3.3. Delayed Matching to Sample (DMS)
A test of delayed memory and forced decision-making. A non-
ﬁgurative pattern is displayed on the screen. Subjects must recall
it and distinguish it from three similar patterns after a delay of 0, 4
or 12 s.
2.3.4. Stockings of Cambridge (SOC)
A test of executive function, speciﬁcally spatial planning and
spatial working memory. The subject has to move coloured circles
arranged in stacks to match a given template. Difﬁculty increases
with the number of moves required. Should the subject make more
than double the number of moves required for the simplest solu-
tion, the problem is terminated. If three problems in a row are
terminated, the entire test is terminated.2.3.5. Intra-/extradimensional set shift (IED)
A test of executive function, attention and ﬂexibility. The sub-
ject has to select the correct ﬁgure from two alternatives according
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o a rule that is acquired from feedback (correct/incorrect). After
ix subsequent correct selections, the rule changes as the test pro-
resses to the next stage. The subject must discover new rules and
dhere to them in order to progress through up to nine stages.
he stages include reversal, intradimensional shift and extradimen-
ional shift. The test terminates after 50 trials in any given stage.
.4. Data handling
Data relating to CA and resuscitation were retrieved from the
riginal cohort.12 HADS and EQ-5D-5L questionnaires were scored
nd reviewed by EAB and KKS. Data about medical history and
reatment following the return of spontaneous circulation (ROSC)
ere retrieved retrospectively from the electronic patient journal
y EAB. All data were registered in a dedicated database in Helse
ergen by EAB and KKS.
.5. Statistics
Mean scores are reported with the 95% conﬁdence inter-
al in brackets. Categorical data were analysed using chi-square
ests without continuity correction, and conﬁdence intervals
or the difference between proportions were calculated using
he Agresti–Caffo method.18 Correlations were calculated using
earson’s product–moment correlation. Simple and multiple
egressions were performed to investigate whether cognitive func-
ion could be predicted. Survival data were retrieved from the
lectronic patient journal and compared to Norwegian life tables.19
ife tables for 2009 were used for subsequent years, since mortal-
ty.org only contained life table series up to 2009. All statistical
nalyses were conducted in R version 3.1.1.20
.6. Ethics
The study was conducted in accordance with the protocol
pproved by the Regional Committee for Medical and Health
esearch Ethics (2012/1701/REK vest). Written consent was
btained from all subjects.
. Results
.1. Demographic and medical characteristics
Of the initial 61 CA survivors, one had unknown identity. Forty-
ix of the remaining 60 were alive at the start of the study. Four
ad CPC > 2 on hospital discharge, one could not be reached and 11
eclined to participate (Fig. 1). None of the 30 patients included
ad known pre-existing brain damage or brain disease, demen-
ia, psychiatric disease or were using or abusing central inhibiting
r stimulating medication. There were no statistically signiﬁcant
ifferences in the distribution of age, gender, medical history or
reatment between included patients and patients who declined to
articipate or could not be reached (Table 1).
.2. Treatment
Of the 30 included patients, 24 had coronary angiography per-
ormed during their hospital stay, while 16 had percutaneous
oronary intervention performed. Only 1 of 30 had surgery with
oronary artery bypass grafting, while 7 of 30 were treated with
herapeutic hypothermia (TH). The duration of resuscitation was
onger among the included patients than among the patients who
eclined to participate or could not be reached (Table 1).tion 89 (2015) 13–18 15
3.3. Survival
At the start of the study, 14 of 55 Norwegian patients with
CPC ≤ 2 discharged alive with known identity were deceased (Fig.
W1). The expected number of deaths in an age and gender-matched
Norwegian population was 5.0 (standardised mortality ratio: 2.8;
95% CI: 1.6–4.5; p < 0.001).19
3.4. Depression and health-related quality of life
The mean score for EQ-VAS was 70.6 (95% CI: 63.4–77.8), com-
pared to 80.0 (95% CI: 79.1–80.9) for an age and gender-matched
Danish normal population.21 The mean score for the EQ-index was
0.85 (95% CI: 0.79–0.90), compared to 0.86 (95% CI: 0.85–0.87) for
the same reference population. The mean score for HADS-A was 3.7
(95% CI: 2.6–4.9) and 3.5 for HADS-D (95% CI: 2.2–4.7). For HADS-
A, 2 of 30 (7%) patients scored ≥8, suggesting anxiety, whereas for
HADS-D, 5 of 30 (17%) patients scored ≥8, suggesting depression.
Correlations between cognitive function and depression or health-
related quality of life were moderate and not statistically signiﬁcant
(Table W1).
3.5. Cognition
All participants passed the Motor Screening test and were
allowed to attempt the cognitive tests. According to the criteria, 29%
(8/28; 95% CI: 15–47%) of the patients were cognitively impaired.17
One of them had CPC 2 on hospital discharge. Nine of the ten z-
scores had mean values lower than zero, and three of them were
statistically signiﬁcant from zero (Table 2 and Fig. 2). Only one
remained so after adjusting for multiple testing. All signiﬁcant z-
scores represent visual memory. To test sensitivity, we performed
bootstrap tests and constructed bootstrap conﬁdence intervals for
the mean of the ten z-scores. The results (not shown) were very
similar to the results of the t-tests, both for p-values and conﬁdence
intervals.
In the multiple regression analysis, OHCA was  a statistically sig-
niﬁcant predictor, with OHCA indicating better cognitive function
(Table 3).
For reversal stages (stages 5, 7 and 9) of the intra-
/extradimensional set shift (IED), the mean number of errors was
18.7. For non-reversal stages (stages 4, 6 and 8), the mean num-
ber of errors was  16.1 (95% CI for difference: −1.4 to 6.5; p = 0.20).
The total number of trials in IED intradimensional shift (ID, stage
6) was  6.5 (95% CI: 5.3–7.7) versus 24.8 (95% CI: 18.0–31.6) for the
extradimensional shift (ED, stage 8) (difference: 18.3; 95% CI for
difference: 11.8–24.8; p < 0.001) (Fig. 3).
For the Delayed Matching to Sample (DMS) percentage correct
at 0 s delay, the mean was  81.4 (95% CI: 75.4–87.5), whereas, at 12 s
delay, the mean was  68.2 (58.8–77.6) (difference: 13.2; 95% CI for
difference: 5.7 to 20.8; p = 0.001. n = 28) (Fig. W2).
4. Discussion
The main ﬁnding in this study is that cognitive impairment per-
sists in 29% (95% CI: 15–47%) of CA survivors with good neurological
outcome at hospital discharge four years after arrest.10,22 The pat-
tern of impairment indicates dysfunction in medial temporal lobe
structures, as seen, for instance, in early Alzheimer’s dementia.23
We  found memory impairments in the Paired Associates Learning
(PAL) and a marked decrease in correct answers at 12 s delay, com-
pared to 0 s delay, in the Delayed Matching to Sample (DMS). Both
ﬁndings correlate with the hippocampus being affected.24 As DMS
and PAL both have spatial properties, low scores in both tests indi-
cate that the medial temporal lobes are affected. These structures
are important for processing spatial information.
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Table  1
Demographic and medical characteristics.
Included Declineda 95% CIb P-value
Age (mean) 62 61 –16 to 14 0.90
Male  gender 24/30 80% 10/12 83% –26 to 25 0.80
Medical history
No previous illness 6/30 20% 4/12 33% –43% to 15% 0.36
Coronary disease 12/30 40% 4/12 33% –25% to 35% 0.69
Heart  failure 8/30 27% 2/12 17% –20% to 33% 0.49
Hypertension 12/30 40% 4/12 33% –25% to 35% 0.69
Lung  disease 5/30 17% 1/12 8% –18% to 27% 0.49
Diabetes 5/30 17% 3/12 25% –37% to 17% 0.53
Stroke 4/30 13% 0/12 0% –10% to 27% 0.18
Malignancy 5/30 17% 0/12 0% –7% to 31% 0.13
Smoke 9/29 31% 3/11 27% –29% to 31% 0.82
Hypercholesterolemia 11/30 37% 4/12 33% –28% to 32% 0.84
Primary rhythm 0.43
Ventricular ﬁbrillation 23/29 79% 6/11 55% – –
Ventricular tachycardia 2/29 7% 1/11 9% – –
Pulseless electric activity 2/29 7% 2/11 18% – –
Asystole 2/29 7% 2/11 18% – –
Presumed cause of arrest 0.32
Cardiac 26/30 87% 8/12 67% – –
Respiratory 2/30 7% 2/12 17% – –
Drowning 0/30 0% 1/12 8% – –
Trauma 1/30 3% 0/12 0% – –
Other  1/30 3% 1/12 8% – –
Resuscitation
Duration of resuscitation (s) 1086 282 –1297 to –310 0.002*
Pre-hospital cardiac arrest 17/30 57% 6/12 50% –21% to 32% 0.69
Witnessed cardiac arrest 28/30 93% 10/12 83% –12% to 36% 0.32
Bystander CPR 26/60 87% 6/12 50% –63% to –5% 0.01*
Treatment
Coronary angiography 24/30 80% 7/12 58% –9% to 51% 0.15
PCI  16/30 53% 5/12 42% –21% to 41% 0.49
CABG  1/30 3% 1/12 8% –28% to 12% 0.49
Therapeutic hypothermia 7/30 23% 3/12 25% –32% to 24% 0.91
CI, conﬁdence interval; CPR, cardio-pulmonary resuscitation; PCI, percutaneous coronary intervention; CABG, coronary artery bypass grafting.
a Declined participation, unknown ID or no contact established.
b 95% CI of mean/percentage difference.
* P-value < 0.05.
Table 2
Mean z-score for ten outcome parameters from four CANTAB tests.
n Mean z-score 95% CI P-value
PAL – ﬁrst trial memory score 30 −0.72 −1.03 to −0.41 <0.001*
PAL – stages completed 30 −0.21 −0.63 to 0.22 0.33
PAL  – total trials (adjusted) 30 −0.47 −0.93 to −0.01 0.05*
DMS  – total correct (all delays) 28 −0.12 −0.62 to 0.39 0.64
DMS  – mean latency to correct (all delays) 28 −0.73 −1.29 to −0.17 0.01*
SOC – problems solved in minimum moves 29 0.12 −1.14 to 0.17 0.56
SOC  – mean thinking time (5 moves) 29 −0.33 −0.94 to 0.05 0.17
SOC  – mean moves (5 moves) 29 −0.34 −0.30 to 0.53 0.12
IED  – stages completed 28 −0.48 −0.80 to 0.14 0.14
IED  – total errors 28 −0.45 −0.78 to 0.09 0.08
CI, conﬁdence interval; PAL, paired associates learning; IED, intra-/extradimensional set shift; DMS, delayed matching to sample; SOC, stockings of Cambridge.
* P-value < 0.05.
Fig. 2. Dot plot showing patient z-scores on 10 parameters from 4 CANTAB tests (n = 28, 29 or 30).
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Table  3
Regression of mean z-score on possible predictors.
Multiple regression Simple regression
Estimatea P-value 95% CI Estimatea P-value 95% CI
Intercept −0.56 −0.95 to −0.17
Non-shockable rhythm 0.36 0.28 −0.32 to 1.04 0.35 0.25 −0.26 to 0.99
OHCA  0.52 0.04 0.04 to 1.00 0.37 0.08 −0.04 to 0.79
Therapeutic hypothermia −0.20 0.63 −1.03 to 0.64 −0.08 0.74 −0.59 to 0.42
LOS  ICU −0.02 0.67 −0.10 to 0.07 −0.01 0.81 −0.06 to 0.05
R2 = 0.23. Adjusted R2 = 0.09.
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tI, conﬁdence interval; OHCA, out-of-hospital cardiac arrest; LOS, length of stay; IC
a Regression coefﬁcient.
Several mechanisms for ischaemic brain damage have been
dentiﬁed. They include impaired cerebral reperfusion, apopto-
is and alterations in gene expression, chemical phenotype and
nfolded protein response.25,26 In severe cases of ischaemic brain
amage, the histopathologic pattern shows a typical distribution
ffecting the medial temporal lobes, cerebellum and neocortex.27
hese areas of the brain control memory and executive functions.
onsidering the physiologic substrate, one would expect the exec-
tive functions to be affected in our patients. This has previously
een documented in CA survivors one and two years after an
rrest.8,10 The ﬁve selected z-scores representing executive func-
ions were not affected in our patients. Hence, a detailed analysis
f the intra-/extradimensional set shift (IED) test was  performed in
rder to look for similarities between CA survivors, on the one hand,
nd patients with Alzheimer’s dementia and patients with frontal
ariant frontotemporal dementia, on the other. These patients
ave lesions in regions of the brain that are also at risk in global
ig. 3. Dot plot showing number of trials in the intradimensional set shift stage (ID)
nd  the extradimensional set shift stage (ED) of the intra-/extradimensional set shift
est (IED) (n = 28).nsive care unit.
hypoxia. Patients with frontal variant frontotemporal dementia
show decreased performance on reversal stages of the IED, which
correlates with social disinhibition and inappropriate behaviour.28
Such a ﬁnding might correspond to reports of personality changes
and altered behaviour in CA survivors. Patients with Alzheimer’s
dementia show signs of excessive suppression of irrelevant infor-
mation, a trait which corresponds to the number of trials in the
Extradimensional Shift (ED) stage of the IED.23 We  found no pattern
in the IED suggesting similarities with frontal variant frontotempo-
ral dementia. There was, however, a pattern comparable to the one
found in early stages of Alzheimer’s dementia (Fig. 3). This may  be
explained by the ‘creative hypothesis’, whereby patients have many
creative solutions to a problem at hand but fail to take previously
irrelevant information into account.23
Increased mortality among CA survivors who were cognitively
impaired might explain the low frequency of cognitive impair-
ment in our material.29 Our CA survivors have a standardised
mortality rate of 2.8 (95% CI: 1.6–4.5), compared to an age and
gender-matched Norwegian population. The mortality is higher
than expected up until three years after CA (Fig. W1). If excess
mortality were to explain the performance in cognitive tests, one
would expect both memory and executive functions to be close to
the norm. Memory impairment was  clear in our patients, but exec-
utive functions were only slightly affected in the extradimensional
shift stage of the IED. An alternative explanation is that patients
have developed strategies to deal with executive dysfunction over
the years following CA. This is not unlikely, since executive dysfunc-
tion may  improve through a mindful approach to real-life tasks that
pose problems.30 In contrast, the treatment of amnesia is limited.
The quality of life report is similar to a Danish age and gender-
matched reference population when measured on the EQ-index
derived from the ﬁve dimensions of health, but signiﬁcantly lower
than the reference when measured on the EQ-VAS. We  have no
clear explanation for this difference. One could speculate that cere-
bral ischaemia reduces spatial awareness and thus affects patient
responses to visual analogue scales. However, this would question
the use of visual analogue scales in large patient groups, and there
is no scientiﬁc basis in our study to support this.
In the regression analysis, OHCA appears to be a predictor of
improved long-term CF. Due to the small sample size, multiple vari-
ables in the model and a p-value close to the limit of signiﬁcance,
we question the reproducibility of such a ﬁnding. Repeated studies
with larger sample sizes are needed to establish causality.
The main strength of our study is standardised, detailed
cognitive testing using computer-based test delivery. The two
investigators followed a strict protocol and cognitive testing was
conducted in public health facilities to ensure similar conditions
for all patients. Limitations include the small sample size and lack
of information about physical health at the time of investigation.
A lack of Norwegian population norms has led us to use Danish
norms for EQ5D and British norms for CANTAB, both of them close
approximations of the parent population, in our opinion.
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Given a European population of 740 million and 3.7 million hos-
ital beds, an estimated 186,000 persons are discharged following
A in Europe each year.31–34 At least 90,000 of these patients are
till alive one year after CA, and between 25,000 and 40,000 of them
ill have mild cognitive impairment.10,29,35 The health impact is
arge in a European perspective and, in our opinion, it must be
ystematically addressed. Patients and their families need to be
nformed about the possibility of cognitive impairment following
A. If there is any suspicion of cognitive impairment that affects
uality of life one year after CA, it should be documented. Thor-
ugh neuropsychological evaluation on such a scale is not feasible,
ince it is time-consuming and dependent on highly trained per-
onnel. In our opinion, CANTAB can serve as a screening tool to
dentify patients for neuropsychological evaluation where cogni-
ive impairment is suspected.
. Conclusions
Cognitive impairment four years after cardiac arrest seems com-
arable to early Alzheimer’s dementia. Memory appears to be
redominantly affected, with executive functions being slightly
ffected.
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